Your browser doesn't support javascript.
loading
External Validation of the MSKCC and IMDC Risk Models in Patients Treated with Targeted Therapy as a First-line and Subsequent Second-line Treatment: A Japanese Multi-institutional Study.
Tanaka, Nobuyuki; Mizuno, Ryuichi; Ito, Keiichi; Shirotake, Suguru; Yasumizu, Yota; Masunaga, Ayako; Ito, Yujiro; Miyazaki, Yasumasa; Hagiwara, Masayuki; Kanao, Kent; Mikami, Shuji; Nakagawa, Ken; Momma, Tetsuo; Masuda, Takeshi; Asano, Tomohiko; Oyama, Masafumi; Oya, Mototsugu.
Affiliation
  • Tanaka N; Department of Urology, Keio University School of Medicine, Tokyo, Japan; Department of Urology, Saitama City Hospital, Saitama, Japan. Electronic address: urotanaka@gmail.com.
  • Mizuno R; Department of Urology, Keio University School of Medicine, Tokyo, Japan.
  • Ito K; Department of Urology, National Defense Medical College, Tokorozawa, Japan.
  • Shirotake S; Department of Uro-Oncology, Saitama Medical University International Medical Center, Hidaka, Japan.
  • Yasumizu Y; Department of Uro-Oncology, Saitama Medical University International Medical Center, Hidaka, Japan.
  • Masunaga A; Department of Urology, National Defense Medical College, Tokorozawa, Japan.
  • Ito Y; Department of Urology, Saiseikai Central Hospital, Tokyo, Japan.
  • Miyazaki Y; Department of Urology, Keio University School of Medicine, Tokyo, Japan.
  • Hagiwara M; Department of Urology, Ichikawa General Hospital, Tokyo Dental College, Ichikawa, Japan.
  • Kanao K; Department of Urology, Aichi Medical University School of Medicine, Nagakute, Japan.
  • Mikami S; Division of Diagnostic Pathology, Keio University Hospital, Tokyo, Japan.
  • Nakagawa K; Department of Urology, Ichikawa General Hospital, Tokyo Dental College, Ichikawa, Japan.
  • Momma T; Department of Urology, National Hospital Organization Saitama Hospital, Wako, Japan.
  • Masuda T; Department of Urology, Saitama City Hospital, Saitama, Japan.
  • Asano T; Department of Urology, National Defense Medical College, Tokorozawa, Japan.
  • Oyama M; Department of Uro-Oncology, Saitama Medical University International Medical Center, Hidaka, Japan.
  • Oya M; Department of Urology, Keio University School of Medicine, Tokyo, Japan.
Eur Urol Focus ; 2(3): 303-309, 2016 Aug.
Article in En | MEDLINE | ID: mdl-28723377

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Eur Urol Focus Year: 2016 Document type: Article Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Eur Urol Focus Year: 2016 Document type: Article Country of publication: Netherlands